Combining incretin-based drugs and RAAS inhibitors: more cons than pros?

Title
Combining incretin-based drugs and RAAS inhibitors: more cons than pros?
Authors
Keywords
-
Journal
Lancet Diabetes & Endocrinology
Volume 2, Issue 9, Pages 684-685
Publisher
Elsevier BV
Online
2014-08-11
DOI
10.1016/s2213-8587(14)70167-6

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started